• 1 January 1982
    • journal article
    • review article
    • Vol. 27  (10) , 639-646
    • PMID:7175834
Abstract
The physiologic anemia of midpregnancy arguably is beneficial in terms of the associated hypervolemia and improved pregnancy outcome. Vigorous treatment of normal pregnant women having physiologic anemias with large doses of medicinal Fe is discouraged because higher hematocrits are reported to be less efficient in terms of cardiac work and O2 delivery, because lower serum Fe levels protect against infection, and because of the hazards of infant Fe poisoning. Pharmacologic doses of Fe also obscure the decline in hematocrit seen from the plasma volume expansion in normal pregnancy, removing a simple diagnostic sign of maternal hypovolemia.